10-QPeriod: Q2 FY2006

EIDP, Inc. Quarterly Report for Q2 Ended Jun 30, 2006

Filed August 4, 2006For Securities:CTA-PBCTA-PA

Summary

E. I. du Pont de Nemours and Company (DuPont) reported a slight decrease in net sales for the second quarter and first six months of 2006 compared to the prior year, primarily due to the divestiture of elastomers businesses and foreign currency effects. Despite this, the company demonstrated resilience with stable or slightly improved pricing and volume in key segments, particularly outside the U.S. Net income saw a modest decline, influenced by higher raw material and energy costs, though productivity initiatives helped offset these pressures. DuPont continues to invest in strategic growth areas like industrial biotechnology and biofuels through partnerships, indicating a forward-looking approach. The company also maintained its commitment to shareholder returns through consistent dividend payments and ongoing share repurchase programs. While facing challenges from raw material cost inflation and ongoing legal matters, the company's diversified operations and strategic investments suggest a stable outlook.

Key Highlights

  • 1Net sales for the second quarter were $7.442 billion, a slight decrease of 1% from $7.511 billion in the prior year, primarily due to the absence of former elastomers businesses and currency fluctuations.
  • 2Net income for the second quarter was $975 million ($1.04 EPS) compared to $1.015 billion ($1.01 EPS) in the prior year, with the current year's EPS benefiting from a reduced share count.
  • 3The company is investing in strategic partnerships, including a new venture with BP for biofuel development and licensing agreements in agriculture.
  • 4Restructuring charges of $135 million were recorded in the first quarter within the Coatings & Color Technologies segment as part of a transformation plan aimed at improving profitability and efficiency.
  • 5The company's effective tax rate decreased significantly in Q2 2006 to 22.2% from 33.2% in Q2 2005, partly due to changes related to foreign currency hedging.
  • 6Despite a decrease in cash provided by operating activities for the first six months ($68 million vs. $431 million in 2005), the company believes its liquidity and access to capital markets are adequate.
  • 7Significant legal matters, including those related to PFOA and Benlate, continue to be disclosed, with management noting that while potential losses are possible, a reasonable estimate of the range of losses is not currently feasible for all matters.

Frequently Asked Questions

Net sales decreased slightly by 1% to $7.442 billion. This was primarily due to the absence of sales from elastomers businesses transferred to Dow in the prior year ($213 million) and unfavorable currency exchange rates, partially offset by a 1% increase in U.S. dollar selling prices and a 1% increase in volume. Sales growth in regions outside the U.S., particularly Asia Pacific and Latin America, was strong, but this was offset by a decrease in U.S. sales, largely due to lower crop protection product sales.

Net income for the second quarter was $975 million, a decrease of approximately 4% from $1.015 billion in the prior year. Diluted earnings per share were $1.04, up from $1.01 in the prior year, benefiting from a reduction in the average number of shares outstanding due to share repurchases. The decrease in net income was influenced by higher year-over-year energy and raw material costs, which were partially offset by higher selling prices, improved licensing income, and ongoing productivity initiatives.

DuPont is continuing to invest in new products and emerging business opportunities. Key initiatives mentioned include new licensing agreements in the Agriculture & Nutrition segment, and a significant partnership with BP to develop, produce, and market biofuels. The company is also executing a transformation plan in its Coatings & Color Technologies segment aimed at improving profitability and consolidating operations.

Yes, DuPont continues to address significant legal and environmental matters. These include ongoing litigation related to BenlateÒ fungicide and environmental concerns surrounding PFOA (perfluorooctanoic acid), including EPA complaints and class-action lawsuits. The company also faces antitrust investigations in synthetic rubber markets. While reserves have been established for some matters, for others, the ultimate liability or range of potential loss cannot be reasonably estimated at this time.